A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
A Phase II Study of Docetaxel, Carboplatin With and Without Low Dose Radiation as Induction Therapy in Locally Advanced Head and Neck Cancer
Sponsor: Susanne Arnold
Listed as NCT02126969, this PHASE2 trial focuses on Head and Neck Cancer and Larynx and remains completed. Sponsored by Susanne Arnold, it has been updated 13 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Apr 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Sep 2022 — Apr 2023 [monthly]
Active Not Recruiting PHASE2
-
Sep 2021 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
▶ Show 8 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Jul 2019 — Oct 2020 [monthly]
Active Not Recruiting PHASE2
Status: Completed → Active Not Recruiting
-
Apr 2019 — Jul 2019 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Aug 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Susanne Arnold
For direct contact, visit the study record on ClinicalTrials.gov .